Press release

AmerisourceBergen & Good Neighbor Pharmacy Surpass 5 Million Vaccine Doses Allocated through its Federal Retail Pharmacy Program for COVID-19 Vaccination

Conshohocken, Pa. (April 4, 2022) – Good Neighbor Pharmacy, AmerisourceBergen’s nationwide network of independent community pharmacies, today announced that it has exceeded 5 million COVID-19 vaccine doses allocated to independent pharmacies across the U.S. This allocation effort is a part of the Federal Retail Pharmacy Program for COVID-19 Vaccination, a collaboration between the Federal Government, U.S. states and territories, and 21 national pharmacy partners, which includes Good Neighbor Pharmacy

With COVID-19 vaccines authorized for people five years and older, independent pharmacies remain an essential healthcare destination in communities, educating and vaccinating eligible individuals against the virus. Pharmacists have helped administer COVID-19 vaccines in communities across the country by hosting clinics and going above and beyond to help those in need, including uninsured populations, long-term care residents, unsheltered individuals and more. Since February of 2021, Good Neighbor Pharmacy has supported more than 1,600 independent community pharmacies in 45 states, Puerto Rico and Guam. 

“We’re incredibly proud of this milestone,” said Jennifer Zilka, President of Good Neighbor Pharmacy. “I’m constantly in awe of what pharmacists have been able to accomplish – from finding ways to be there for their patients during the pandemic to all the education, testing and vaccinations for COVID-19. I think the nation has witnessed the capabilities, value and care pharmacists and their teams can deliver. And I just want to say thank you to all the pharmacists out there. You’re all an inspiration.”

Nearly 52% of pharmacies within AmerisourceBergen and Good Neighbor Pharmacy Federal Retail Pharmacy Program are in socially vulnerable communities, as outlined by the CDC’s Social Vulnerability Index. Nearly 50% of the patients that received a vaccine through Good Neighbor Pharmacy’s program reside in socially vulnerable communities.

Jasmine Chan, Pharmacist at Central Avenue Pharmacy (CAPrx), who has hosted clinics outside of Monterey, Calif. for unsheltered community members and has hiked hills across Monterey County to find and help those living in homeless encampments, added, “As a pharmacist on the front lines, equitable access continues to be a priority for not only vaccines and booster shots, but also tests and treatments. My pharmacy has made it a point to reach out to community members who may face technology or transportation barriers and assist them. For individuals who don’t speak English or are undocumented, we adjusted processes to accommodate them. We also coordinated and operated mobile vaccine clinics for hard-to-reach populations. I know that I’m one of the thousands of independent pharmacists doing this type of work. It has been an honor and privilege to help serve in this capacity.”

For more information on how independent pharmacies across the nation continue to step up in their communities, check out Good Neighbor Pharmacy’s Fearless Pharmacy page: https://www.wearegnp.com/fearless-pharmacy.

About AmerisourceBergen
AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies and providers, we create unparalleled access, efficiency and reliability for human and animal health. Our 42,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #8 on the Fortune 500 with more than $200 billion in annual revenue. Learn more at www.amerisourcebergen.com

Press release

IntrinsiQ Specialty Solutions Expands Data Capabilities, Empowering Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

October 16, 2025

Media statement

Cencora to Support Commercial Launch of Precigen’s Novel Immunotherapy in the United States

September 24, 2025

Media mention

ThoughtSpot 2025 Highlights Cencora’s Commitment to Advancing the Future of Pharmacy and Ensuring Medication Access

August 27, 2025

Media contacts

Need help or have questions?  Send us a message and we'll get back to you soon.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.